Annual revenues of Swedish biopharma company Sobi increased from around 6.5 billion Swedish kronor in 2017, up to the highest value of around 22.1 billion Swedish kronor in 2023. The company's full name is Swedish Orphan Biovitrum AB. Sobi is specialized on the treatment of rare diseases. This statistic illustrates the annual revenue of Sobi from 2009 to 2023.
Annual revenue of Sobi from 2009 to 2023
(in million SEK)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Sobi. (April 2, 2024). Annual revenue of Sobi from 2009 to 2023 (in million SEK) [Graph]. In Statista. Retrieved December 19, 2024, from https://www.statista.com/statistics/946914/annual-revenue-of-sobi/
Sobi. "Annual revenue of Sobi from 2009 to 2023 (in million SEK) ." Chart. April 2, 2024. Statista. Accessed December 19, 2024. https://www.statista.com/statistics/946914/annual-revenue-of-sobi/
Sobi. (2024). Annual revenue of Sobi from 2009 to 2023 (in million SEK) . Statista. Statista Inc.. Accessed: December 19, 2024. https://www.statista.com/statistics/946914/annual-revenue-of-sobi/
Sobi. "Annual Revenue of Sobi from 2009 to 2023 (in Million Sek) ." Statista, Statista Inc., 2 Apr 2024, https://www.statista.com/statistics/946914/annual-revenue-of-sobi/
Sobi, Annual revenue of Sobi from 2009 to 2023 (in million SEK) Statista, https://www.statista.com/statistics/946914/annual-revenue-of-sobi/ (last visited December 19, 2024)
Annual revenue of Sobi from 2009 to 2023 (in million SEK) [Graph], Sobi, April 2, 2024. [Online]. Available: https://www.statista.com/statistics/946914/annual-revenue-of-sobi/
